A Variation in 3′ UTR of hPTP1B Increases Specific Gene Expression and Associates with Insulin Resistance
Protein tyrosine phosphatase 1B ( PTP1B) inhibits insulin signaling and, when overexpressed, plays a role in insulin resistance (Ahmad et al. 1997). We identified, in the 3′ untranslated region of the PTP1B gene, a 1484insG variation that, in two different populations, is associated with several fea...
Saved in:
Published in | American journal of human genetics Vol. 70; no. 3; pp. 806 - 812 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Chicago, IL
Elsevier Inc
01.03.2002
University of Chicago Press The American Society of Human Genetics |
Subjects | |
Online Access | Get full text |
ISSN | 0002-9297 1537-6605 1537-6605 |
DOI | 10.1086/339270 |
Cover
Loading…
Summary: | Protein tyrosine phosphatase 1B (
PTP1B) inhibits insulin signaling and, when overexpressed, plays a role in insulin resistance (Ahmad et al.
1997). We identified, in the 3′ untranslated region of the
PTP1B gene, a 1484insG variation that, in two different populations, is associated with several features of insulin resistance: among male individuals, higher values of the insulin resistance HOMA
IR index (
P=.006), serum triglycerides (
P=.0002), and total/HDL cholesterol ratio (
P=.025) and, among female individuals, higher blood pressure (
P=.01). Similar data were also obtained in a family-based association study by use of sib pairs discordant for genotype (Gu et al.
2000). Subjects carrying the 1484insG variant showed also
PTP1B mRNA overexpression in skeletal muscle (6,166 ± 1,879 copies/40 ng RNA vs. 2,983 ± 1,620;
P<.01). Finally,
PTP1B mRNA stability was significantly higher (
P<.01) in human embryo kidney 293 cells transfected with 1484insG
PTP1B, as compared with those transfected with wild-type
PTP1B. Our data indicate that the 1484insG allele causes
PTP1B overexpression and plays a role in insulin resistance. Therefore, individuals carrying the 1484insG variant might particularly benefit from
PTP1B inhibitors, a promising new tool for treatment of insulin resistance (Kennedy and Ramachandran
2000). |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0002-9297 1537-6605 1537-6605 |
DOI: | 10.1086/339270 |